Expertise in
11
conditions

Guosheng S. Fu

Sir Run Run Shaw Hospital Of Zhejiang University School Of Medicine
Hangzhou, CN 
Expertise in
11
conditions
Sir Run Run Shaw Hospital Of Zhejiang University School Of Medicine
Hangzhou, CN 

Overview

Guosheng Fu practices practicing medicine in Hangzhou, China.

Fu is highly rated in 11 conditions, according to our data. Their clinical expertise encompasses Coronary Heart Disease, Heart Block, Heart Attack, Percutaneous Coronary Intervention (PCI), and Angioplasty.

They are actively involved in clinical research, co-authoring 257 peer reviewed articles and participating in 4 clinical trials.

Locations

Sir Run Run Shaw Hospital of Zhejiang University School of Medicine
Hangzhou, China
Other Locations
47 Zhonghua Road, Fuxin, 123000, China
No. 79 Qingchun Road, Hangzhou, 310003, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Image Fusion of SPECT MPI and Fluoroscopy Venography to Guide LV Lead Placement for Improved CRT Response (GUIDE-CRT II)
Image Fusion of SPECT MPI and Fluoroscopy Venography to Guide LV Lead Placement for Improved CRT Response (GUIDE-CRT II)
Enrollment Status: Completed
Publish Date: August 17, 2025
Intervention Type: Other
Study Phase: Not Applicable
Comparison of Double Kissing Culotte Stenting With Double Kissing Crush Stenting in the Treatment of True Bifurcation Lesions: a Multicenter, Noninferior, Randomized, Controlled Trial (the DK Culotte-I Study)
Comparison of Double Kissing Culotte Stenting With Double Kissing Crush Stenting in the Treatment of True Bifurcation Lesions: a Multicenter, Noninferior, Randomized, Controlled Trial (the DK Culotte-I Study)
Enrollment Status: Completed
Publish Date: September 27, 2022
Intervention Type: Device
Study Phase: Not Applicable
The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel in Patients With Coronary Atherosclerotic Heart Disease and Planned Percutaneous Coronary Intervention: a Multi-center, Randomized, Double-blind, Triple-dummy , Parallel-controlled, Dose-exploration Phase II Trial
The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel in Patients With Coronary Atherosclerotic Heart Disease and Planned Percutaneous Coronary Intervention: a Multi-center, Randomized, Double-blind, Triple-dummy , Parallel-controlled, Dose-exploration Phase II Trial
Enrollment Status: Completed
Publish Date: September 23, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Phase III, Multi-center,Randomized, Double-blind, Based on Standard Therapy, Placebo-controlled Study of the Survival of Recombinant Human Neuregulin-1β in Patients With Chronic Systolic Heart Failure
A Phase III, Multi-center,Randomized, Double-blind, Based on Standard Therapy, Placebo-controlled Study of the Survival of Recombinant Human Neuregulin-1β in Patients With Chronic Systolic Heart Failure
Enrollment Status: Terminated
Publish Date: December 21, 2017
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

257 Total Publications

Polyporus umbellatus β-glucan ameliorates metabolic dysfunction-associated steatohepatitis by remodeling the gut microbiota-bile acid-FXR signaling axis.
Polyporus umbellatus β-glucan ameliorates metabolic dysfunction-associated steatohepatitis by remodeling the gut microbiota-bile acid-FXR signaling axis.
Journal: Journal of ethnopharmacology
Published: June 06, 2026

Frequently Asked Questions about Guosheng S. Fu

Is Guosheng S. Fu a top-rated expert for Coronary Heart Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Guosheng S. Fu is classified as an Advanced expert for Coronary Heart Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Guosheng S. Fu participate in research or clinical trials?

Yes. Guosheng S. Fu has published 257 articles and abstracts on conditions like Coronary Heart Disease. You can view a list of Guosheng S. Fu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Fu's expertise for a condition
ConditionClose
      View All 11 Advanced Conditions
      View All 29 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile